Taken together, our data indicate that RECQL4 reduces the migration and recruitment of DCs induced by RT, thereby diminishing the activation of CD8+ T cells by suppressing interferon‐γ production, facilitating the oncogenic transformation of the HCC TME. The gene discussed is RECQL4; the disease is hepatocellular carcinoma.